1 2D Structure

2D Structure

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[(2-methoxyphenyl)methyl]-5-phenyl-1,2-oxazole-3-carboxamide

2.1.2 InChI

InChI=1S/C18H16N2O3/c1-22-16-10-6-5-9-14(16)12-19-18(21)15-11-17(23-20-15)13-7-3-2-4-8-13/h2-11H,12H2,1H3,(H,19,21)

2.1.3 InChI Key

JDNAIBCYTQGWFC-UHFFFAOYSA-N

2.1.4 Canonical SMILES

COC1=CC=CC=C1CNC(=O)C2=NOC(=C2)C3=CC=CC=C3

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 148465-45-6

2. Cid 17397714

3. Zinc9497828

4. Akos016487279

5. Z164754034

6. 923916-82-9

2.3 Create Date

2007-11-13

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₆N₂O₃
Molecular Weight	308.3 g/mol
XLogP3	3.1
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	5
Exact Mass	308.11609238 g/mol
Monoisotopic Mass	308.11609238 g/mol
Topological Polar Surface Area	64.4 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	385
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 1
Drug Name	MYTESI
Active Ingredient	CROFELEMER
Company	NAPO PHARMS INC (Application Number: N202292. Patents: 7323195, 7341744, 8574634, 8962680, 9585868)

Technical details about Crofelemer, learn more about the structure, uses, toxicity, action, side effects and more

Crofelemer